SavedAdd your journal

Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2015 / Cilt: 49 - Sayı: 3

Last 18 months experience of laparascopic tuboovarian abcess treatment in our clinics

Kliniğimizde Son 18 Aylık Tubaovaryan Apse Tedavisinde Laparoskopi Deneyimlerimiz

Osman TEMİZKAN
Osman AŞICIOĞLU
Berhan AŞICIOĞLU
Bülent ARICI
Pınar YALÇIN
Işıl AYHAN
Pages
181–186
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Laparascopy is a very efficient and safe way in surgical treatment of tuboovarian abscess in surgically-experienced centers

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Our primary objective in this study was to evaluate whether the size of the abscess affects clinical or laboratory results; also to evaluate efficacy and safety of laparascopy in surgical treat- ment.
📊
Key Findings & Data:Material and Method: 42 patients diagnosed as having tuboovarian abscess (TOA) who did not respond to medical treatment and underwent laparascopic surgery in last 18 monhts in our clinic were retrospectively analysed.
💡
Conclusion & Impact:Conclusion: Laparascopy is a very efficient and safe way in surgical treatment of tuboovarian abscess in surgically-experienced centers
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Our primary objective in this study was to evaluate whether the size of the abscess affects clinical or laboratory results; also to evaluate efficacy and safety of laparascopy in surgical treat- ment. Material and Method: 42 patients diagnosed as having tuboovarian abscess (TOA) who did not respond to medical treatment and underwent laparascopic surgery in last 18 monhts in our clinic were retrospectively analysed. Results: Mean age of patients was 38.7 years. 16.6% of those were postmenopausal and 14.2% had intrauterine device. Fever above 38 degrees celcius, c-reactive protein (CRP), erithrocyte sedimenta- tion rate, leukocyte count were significantly higher in the group of patients who had abscesses over 7 centimeters. Only one patient had thermal urether injury, none needed secondary operation. Conclusion: Laparascopy is a very efficient and safe way in surgical treatment of tuboovarian abscess in surgically-experienced centers

Özet

Amaç: Çalışmada primer amacımız tubaovaryan apse tanılı hastalarda apse boyutunun klinik ve labo- ratuar sonuclarına etkisi ve cerrahi tedavide laparoskopi yönteminin etki ve güvenililirliğini değer- lendirmek. Gereç ve Yöntem: Kliniğimizde son 18 aylık dönemdeki tubaovaryan apse (TOA) tanısıyla medikal tedaviye yanıt vermeyen 42 adet laparoskopi yapılan hasta retrospektif incelendi. Bulgular: Yapılan değerlendirmede hastaların ortalama yaşı 38.7 olarak belirlendi. Bu hastaların %16.6sı menopoz sonrası dönemde iken, %14.2sinde RİA mevcuttu. Ayrıca apse boyutu 7 cm üzerin- de olan grupta 38 derece ustu ateşli hasta oranı, C-reaktif protein (CRP), eritrosit sedimentasyon hızı (ESH) ve lökosit sayısı anlamlı olarak yüksek bulundu. Yapılan 42 laparoskopi operasyonunda sadece 1 hastada termal ureter hasarı oldu ve ikincil operasyon hiçbir hastaya gerekmedi. Sonuç: Yeterli cerrahi tecrübe olan kliniklerde TOA cerrahi tedavisinde laparoskopi oldukça güvenli ve etkili bir tedavi olarak görünmektedir.

🔖

Cite This Article

TEMİZKAN, O., AŞICIOĞLU, O., AŞICIOĞLU, B., ARICI, B., YALÇIN, P., AYHAN, I. (2015). Last 18 months experience of laparascopic tuboovarian abcess treatment in our clinics. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 49 - Sayı: 3, 181–186. https://ajindex.com/articles/363837

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Chappell CA, Wiesenfeld HC. Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess. Clin Obstet Gynecol 2012;55:893-903
  2. McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. Am J Obstet Gynecol 1998;178:1272–8
  3. Franklin LW, Hevron JE, Thompson. ‘’Management of the pelvic abscess’’ Clinical Obstetrics and Gynecology 1973;16:66-79 4. Ginsburg DS, Stern JL, Hamod KA, Genadry R, Spence MR.Tubo- ovarian abscess: a retrospective review. Am J Obstet Gynecol 1980;138:1055-58
  4. Granberg S, Gjelland K, Ekerhovd E. Best practice and research. ÊClinical Obstetrics and Gynecology. 2009;23:667-78
  5. Güngördük K, Guzel E, Asicioğlu O, Yildirim G, Ataser G, Ark C. Et all. Experience of tubo-ovarian abscess in western Turkey. Int J Gynaecol Obstet. 2014 Jan;124:45-50
  6. Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993;36:433–44
  7. Landers DV, Sweet RL. Tubo-ovarian abscess: contemporary approach to management. Rev Infect Dis 1983;5:876–84
  8. Porpora MG, Gomel V. The role of laparoscopy in the management of pelvic pain in women of reproductive age. Fertil Steril. 1997;68:765-79
  9. Varras M, Polyzos D, Perouli E, Noti P, Pantazis I, Akrivis Ch. Tubo-ovarian abscesses: spectrum of sonographic findings with surgical and pathological correlations. Clin Exp Obstet Gynecol 2003;30:117–21 11. Paik Ck, Waetjen LE, Xing G, Dai J, Sweet Rl. Hospitalizations for pelvic inflamatory disease and tuboovarian abscess. Obstet Gynecol.2006;107:611- 6
  10. Sweet RL, Schachter J, LandersDV,Ohm-SmithM, RobbieMO. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline. Am J Obstet Gynecol 1988;158:736–41 13. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991;164:1556–62
  11. Halperin R, Svirsky R, Vaknin Z, Ben-Ami I, Schneider D, Pansky M. Predictors of tuboovarian abscess in acute pelvic inflammatory disease. J Reprod Med 2008;53:40–4
  12. Kaplan AL, Jacobs WM, Ehresman JB. Agressive management of pelvic abscess. Am J Obstet Gynecol 1967;98:482-87
  13. Gjelland K, Ekerhovd E & Granberg S. Transvaginal ultrasound- guided aspiration for treatment of tub